(Q33222363)

English

Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Neisseria gonorrhoeae

0 references

oligosaccharide

1 reference

based on heuristic

inferred from title

author name string

Jutamas Ngampasutadol

1

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Peter A Rice

2

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Mary T Walsh

3

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Sunita Gulati

4

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

language of work or name

0 references

publication date

10 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

157-170

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. Role of antibodies directed against lipooligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Opsonophagocytosis of Neisseria gonorrhoeae: interaction of local and disseminated isolates with complement and neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Structural and immunochemical characterization of a Neisseria gonorrhoeae epitope defined by a monoclonal antibody 2C7; the antibody recognizes a conserved epitope on specific lipo-oligosaccharides in spite of the presence of human carbohydrate epit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Epitope expression of gonococcal lipooligosaccharide (LOS). Importance of the lipoidal moiety for expression of an epitope that exists in the oligosaccharide moiety of LOS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Identification of the gene (lgtG) encoding the lipooligosaccharide beta chain synthesizing glucosyl transferase from Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Complement-mediated bacterial killing assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

A family of concanavalin A-binding peptides from a hexapeptide epitope library

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Peptide ligands for a sugar-binding protein isolated from a random peptide library

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Synthetic vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Synthetic peptide immunogens as vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Production of an atrial natriuretic peptide variant that is specific for type A receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

All-D peptides recognized by an anti-carbohydrate antibody identified from a positional scanning library.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Peptide mimics elicit antibody responses against the outer-membrane lipooligosaccharide of group B neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

A structure-based approach to a synthetic vaccine for HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Generation of anti-peptide and anti-protein sera effect of peptide presentation on immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Cyclic V3-loop-related HIV-1 conjugate vaccines. Synthesis, conformation and immunological properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Thymus-independent and thymus-dependent responses to polysaccharide antigens

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

based on heuristic

inferred from DOI database lookup

C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Complement-fixing IgG1 constitutes a new subclass of mouse IgG

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Isotypes of mouse IgG--I. Evidence for 'non-complement-fixing' IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Human vaccination with Escherichia coli J5 mutant induces cross-reactive bactericidal antibody against Neisseria gonorrhoeae lipooligosaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.065

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.07.065

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33222363&oldid=1969930576"